Citation Impact
Citing Papers
Diabetes and Cardiovascular Disease
1999 Standout
Targeting of Cyclic AMP Degradation to β 2 -Adrenergic Receptors by β-Arrestins
2002 StandoutScienceNobel
Effect of C1 Inhibitor on Inflammatory and Physiologic Response Patterns in Primates Suffering from Lethal Septic Shock
1998
Platelet alpha-granule proteins: studies on release and subcellular localization
1979
Is clinical outcome of dengue-virus infections influenced by coagulation and fibrinolysis? A critical review of the evidence
2003
Heparin coating of extracorporeal circuits inhibits contact activation during cardiac operations
1997
Mechanisms of Thrombus Formation
2008 Standout
The Molecular Biology of Cyclic Nucleotide Phosphodiesterases
1999
Calcium's Role in Mechanotransduction during Muscle Development
2014 Standout
Insulin, insulin resistance and platelet function: similarities with insulin effects on cultured vascular smooth muscle cells
1998
Antibody, Macrophages, Dengue Virus Infection, Shock, and Hemorrhage: A Pathogenetic Cascade
1989
Cyclic nucleotide phosphodiesterase (PDE) superfamily: A new target for the development of specific therapeutic agents
2005 Standout
Human Fibrinogen
1988
Hematopoietic Growth Factors
1989
Calpains (intracellular calcium-activated cysteine proteinases): Structure-activity relationships and involvement in normal and abnormal cellular metabolism
1990
Clinical review: Sepsis and septic shock - the potential of gene arrays
2012
Fibronectin degradation products containing the cytoadhesive tetrapeptide stimulate human neutrophil degranulation.
1988
The Inflammatory Response to Cardiopulmonary Bypass: Part 1—Mechanisms of Pathogenesis
2008
Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy
2005 Standout
Inflammatory response to cardiopulmonary bypass
1993 Standout
The molecular basis of blood coagulation
1988 Standout
Properties and Functions of GAF Domains in Cyclic Nucleotide Phosphodiesterases and Other Proteins
2004
Cloning and Characterization of the Cyclic Guanosine Monophosphate-Inhibited Phosphodiesterase PDE3A Expressed in Mouse Oocyte1
2001
Severe Sepsis and Septic Shock
2013 Standout
Protein adsorption from human plasma is reduced on phospholipid polymers
1991
Disseminated intravascular coagulation: Clinical and laboratory aspects
1998
Enhancement of rabbit jugular vein thrombolysis by neutralization of factor XI. In vivo evidence for a role of factor XI as an anti-fibrinolytic factor.
1998
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
2017 Standout
Mediators of peripheral blood neutrophilia induced by photodynamic therapy of solid tumors
2002
ESDN, a Novel Neuropilin-like Membrane Protein Cloned from Vascular Cells with the Longest Secretory Signal Sequence among Eukaryotes, Is Up-regulated after Vascular Injury
2001 StandoutNobel
Whole blood coagulation on protein adsorption-resistant PEG and peptide functionalised PEG-coated titanium surfaces
2004 StandoutNobel
Complement: a key system for immune surveillance and homeostasis
2010 Standout
Thrombin signalling and protease-activated receptors
2000 StandoutNature
Modulators of coagulation. A critical appraisal of their role in sepsis
1992
Cyclic nucleotide phosphodiesterases: Relating structure and function
2000
Coagulation disorders in septic shock
1993
Comparison of Coagulation Activity Tests In Vitro for Selected Biomaterials
2002
Early activation of bradykinin B2 receptor aggravates reactive oxygen species generation and renal damage in ischemia/reperfusion injury
2006
Photodynamic therapy and anti-tumour immunity
2006 Standout
Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer
1991 Standout
Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes
2004
Cyclic GMP as substrate and regulator of cyclic nucleotide phosphodiesterases (PDEs)
2005
Resistance to Activated Protein C as a Basis for Venous Thrombosis
1994 Standout
Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.
1989 Standout
Dengue
2012 Standout
Dental caries
2007 Standout
C1-inhibitor in patients with severe sepsis and septic shock: Beneficial effect on renal dysfunction
2002
Reducing implant-related infections: active release strategies
2006 Standout
The creation of an antithrombotic surface by apyrase immobilization
2010 StandoutNobel
Receptors for ADP on human blood platelets
1994
Serum protein adsorption and platelet adhesion on pluronic™-adsorbed polysulfone membranes
2003
Ultralow‐Fouling, Functionalizable, and Hydrolyzable Zwitterionic Materials and Their Derivatives for Biological Applications
2009 Standout
Expression and characterization of deletion recombinants of two cGMP-inhibited cyclic nucleotide phosphodiesterases (PDE-3)
1998
Disseminated Intravascular Coagulation
1999 Standout
Surface-adsorbed fibrinogen and fibrin may activate the contact activation system
2008
The contact system contributes to hypotension but not disseminated intravascular coagulation in lethal bacteremia. In vivo use of a monoclonal anti-factor XII antibody to block contact activation in baboons.
1993
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
Differential Regulation of Rho and Rac through Heterotrimeric G-proteins and Cyclic Nucleotides
2001
Distribution of erythropoietin producing cells in rat kidneys during hypoxic hypoxia
1993 StandoutNobel
Identification of the platelet ADP receptor targeted by antithrombotic drugs
2001 StandoutNatureNobel
The molecular pathology of Alzheimer's disease
1991 Standout
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
1987 Standout
Lack of angiotensin II–facilitated erythropoiesis causes anemia in angiotensin-converting enzyme–deficient mice
2000 StandoutNobel
Evaluation of Salivary Gland Acinar and Ductal Cell-Specific Promoters In Vivo with Recombinant Adenoviral Vectors
2001
Immune Thrombocytopenia
1979
Blood coagulation factors V and VIII: structural and functional similarities and their relationship to hemorrhagic and thrombotic disorders
1988
Membrane protein phosphorylation of intact normal and hereditary spherocytic erythrocytes.
1978
Administration of C1 Inhibitor Reduces Neutrophil Activation in Patients with Sepsis
2003
Serpin Structure, Mechanism, and Function
2002 Standout
Tissue factor activity in whole blood
2004
Surface Modifications for Antifouling Membranes
2010 Standout
Neutrophil elastase-releasing factors in bronchoalveolar lavage from patients with adult respiratory distress syndrome.
1985
Potential therapeutic applications of aspirin and other cyclo‐oxygenase inhibitors.
1980
Pro-Carboxypeptidase R is an Acute Phase Protein in the Mouse, Whereas Carboxypeptidase N Is Not
2000 StandoutNobel
Neutrophil Enhancement of Fibrin Deposition Under Flow Through Platelet-Dependent and -Independent Mechanisms
2001
Cloning and characterization of human protease-activated receptor 4
1998
Neutrophil Elastase May Play a Key Role in Developing Symptomatic Disseminated Intravascular Coagulation and Multiple Organ Failure in Patients with Head Injury
2000
Substitution of arginine for Leu444 in the reactive site of heparin cofactor II enhances the rate of thrombin inhibition.
1990
Human plasma kallikrein releases neutrophil elastase during blood coagulation.
1983
Reconstitution of the purified platelet fibrinogen receptor. Fibrinogen binding properties of the glycoprotein IIb-IIIa complex.
1985
Clinical results with gemfibrozil and background to the Helsinki Heart Study
1983
An association between the factor VII coagulant activity and thrombin activity induced by surface/cold exposure of normal human plasma
1986
Desensitization of turkey erythrocyte adenylate cyclase. Beta-adrenergic receptor phosphorylation is correlated with attenuation of adenylate cyclase activity.
1984 StandoutNobel
Prevention and Treatment of Thrombosis in Pediatric and Congenital Heart Disease
2013
Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.
1993 Standout
Self-Assembled Organic Monolayers: Model Systems for Studying Adsorption of Proteins at Aurfaces
1991 StandoutScience
β2-glycoprotein-I (apo-H) inhibits the release reaction of human platelets during ADP-induced aggregation
1987
HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDY
1986 Standout
Bacterial adhesion to polyurethane surfaces in the presence of pre-adsorbed high molecular weight kininogen
1996
Wound Healing: A Cellular Perspective
2018 Standout
Spatiotemporal dynamics of guanosine 3′,5′-cyclic monophosphate revealed by a genetically encoded, fluorescent indicator
2001 StandoutNobel
Protease Nexin-II(amyloid β-protein Precursor): a Platelet α-Granule Protein
1990 Science
Molecular cloning of a potential proteinase activated receptor.
1994
Exposure of fibrinogen receptors in human platelets by surface proteolysis with elastase.
1986
Putting polyphosphates to the test: evidence against platelet-induced activation of factor XII
2013 StandoutNobel
Ca2+Sensitivity of Smooth Muscle and Nonmuscle Myosin II: Modulated by G Proteins, Kinases, and Myosin Phosphatase
2003 Standout
The Vanilloid Receptor: A Molecular Gateway to the Pain Pathway
2001 StandoutNobel
Disseminated intravascular coagulation due to malignancy.
1990
Surface-mediated defense reactions. The plasma contact activation system.
1984
Bradykinin B1 and B2 receptors both have protective roles in renal ischemia/reperfusion injury
2007 StandoutNobel
Contact System: A Vascular Biology Modulator With Anticoagulant, Profibrinolytic, Antiadhesive, and Proinflammatory Attributes
1997
Thrombospondin stimulates motility of human neutrophils.
1990 StandoutNobel
The biology of platelet-derived growth factor
1986 Standout
What really is blood compatibility?
2000
Erythropoietin production in exhypoxic polycythemic mice
1989
Contribution of Plasma Protease Inhibitors to the Inactivation of Kallikrein in Plasma
1982
Effects of simulated extracorporeal circulation on human leukocyte elastase release, superoxide generation, and procoagulant activity
1991
Irreversible Inhibitors of Serine, Cysteine, and Threonine Proteases
2002 Standout
Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H).
1990 Standout
Characterization of the human blood coagulation factor XII gene. Intron/exon gene organization and analysis of the 5'-flanking region.
1987
New Perspectives in Cell Adhesion: RGD and Integrins
1987 StandoutScience
The Pathogenesis of Atherosclerosis — An Update
1986 Standout
ADP Receptors on Platelets
1996
Human neutrophil degranulation during extracorporeal circulation
1987
Interruption of acute platelet-dependent thrombosis by the synthetic antithrombin D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone.
1988
HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOOD
1981 Standout
Assay of factor VII activity by two techniques: evidence for increased conversion of VII to αVIIain hyperlipidaemia, with possible implications for ischaemic heart disease
1985
Works of RW Colman being referenced
Purified plasma factor XIIa aggregates human neutrophils and causes degranulation
1986
High molecular weight kininogen: localization in the unstimulated and activated platelet and activation by a platelet calpain(s)
1986
Platelet activation: role of an ADP receptor.
1986
Effect of heparin on the inactivation rate of human factor XIa by antithrombin-III
1982
Thrombin and human plasma kallikrein inhibition during simulated extracorporeal circulation block platelet and neutrophil activation.
1998
Purified plasma factor XIIa aggregates human neutrophils and causes degranulation
1986
Naturally occurring human antibodies against two distinct functional domains in the heavy chain of FXI/FXIa
1988
High molecular weight kininogen protects human plasma kallikrein and factor XIa against inactivation by plasma protease inhibitors.
1981
Design and synthesis of a kininogen-based selective inhibitor of thrombin-induced platelet aggregation.
1994
Effect of cleavage of the heavy chain of human plasma kallikrein on its functional properties
1985
Human platelet cGI-PDE: expression in yeast and localization of the catalytic domain by deletion mutagenesis
1996
Alpha 1-antitrypsin Pittsburgh (Met358-->Arg) inhibits the contact pathway of intrinsic coagulation and alters the release of human neutrophil elastase during simulated extracorporeal circulation.
1994
Effect of heterologous antibody on human platelets
1976
Subcellular localization and purification of platelet alpha1- antitrypsin
1978
Activation of the kallikrein-kinin system after endotoxin administration to normal human volunteers
1993
Inhibition of thrombin-induced platelet aggregation by high molecular weight kininogen.
1987
Epitope mapping of functional domains of human factor Va with human and murine monoclonal antibodies. Evidence for the interaction of heavy chain with factor Xa and calcium
1987
Evaluation of the plasma kinin system in dengue hemorrhagic fever.
1975
Preservation of platelet number and function with prostaglandin E1 during total cardiopulmonary bypass in rhesus monkeys.
1978
Formation of C1s-C1-inhibitor, kallikrein-C1-inhibitor, and plasmin- alpha 2-plasmin-inhibitor complexes during cardiopulmonary bypass
1989
Mechanism of transient adsorption of fibrinogen from plasma to solid surfaces: role of the contact and fibrinolytic systems
1988
Assay of prekallikrein in human plasma: comparison of amidolytic, esterolytic, coagulation, and immunochemical assays
1982
Kinin activation in the blood of patients with sepsis.
1976
Bovine factor v: a calcium-containing metalloprotein
1975
Recombinant alpha 1-antitrypsin Pittsburgh attenuates experimental gram-negative septicemia.
1988
Assay of prekallikrein in human plasma: comparison of amidolytic, esterolytic, coagulation, and immunochemical assays
1982
Effect of heparin on the inactivation rate of human activated factor XII by antithrombin III
1985
Platelet ADP Receptors Stimulating Shape Change and Inhibiting Adenylate Cyclase
1992
Mechanism of transient adsorption of fibrinogen from plasma to solid surfaces: role of the contact and fibrinolytic systems
1988
Regulatory and catalytic domains of platelet cAMP phosphodiesterases: targets for drug design.
1995
Potassium uptake and release by human blood platelets
1976
Platelet aggregation and exposure of fibrinogen receptors by prostaglandin endoperoxide analogues
1983
Activation of the kallikrein system in hyperbetalipoproteinemia.
1978
Inhibition of collagen-induced platelet activation by 5'-p- fluorosulfonylbenzoyl adenosine: evidence for an adenosine diphosphate requirement and synergistic influence of prostaglandin endoperoxides
1986
Effect of heparin on the inactivation rate of human activated factor XII by antithrombin III
1985
High molecular weight kininogen: localization in the unstimulated and activated platelet and activation by a platelet calpain(s)
1986
Factor XI antigen and activity in human platelets
1982